Objective: To determine the prevalence and risk factors associated with peripheral arterial disease (PAD) in Northern Barcelona at 65 years of age. Methods: A single-center, cross-sectional study, including males and females 65 years of age, health care cardholders of Barcelona Nord. PAD was defined as an ankle-brachial index (ABI) < 0.9. Attending subjects were evaluated for a history of common cardiovascular risk factors. A REGICOR score was obtained, as well as a physical examination and anthropometric measurements. Results: From November 2017 to December 2018, 1174 subjects were included: 479 (40.8%) female and 695 (59.2%) male. Overall prevalence of PAD was 6.2% (95%CI: 4.8-7.6%), being 7.9% (95%CI: 5.9-9.9%) in males and 3.8% (95%CI: ...
Abstract Background: To investigate the presence of peripheral artery disease (PAD) via the ankle br...
To compare the prevalence of lower extremity peripheral artery disease (PAD) and to assess whether a...
Objective To determine cardiovascular comorbidities and use of cardiovascular disease preventive dru...
Asintomático; Factores de riesgo cardiovascular; PrevalenciaAsimptomàtic; Factors de risc cardiovasc...
BACKGROUND: The primary aim of the present study was to determine the cumulative effect of a set of ...
AbstractObjectivesTo determine the prevalence of ankle-brachial index (ABI)<0.9 and symptomatic peri...
Background: the early diagnosis of atherosclerotic disease is essential for developing preventive st...
_Background:_ Cardiovascular diseases (CVD) are the most important cause of mortality in Latin Ameri...
Abstract Background The early diagnosis of atherosclerotic disease is essential for developing preve...
textabstractBackground: Cardiovascular diseases (CVD) are the most important cause of mortality in L...
Objective: To determine the age-standardised prevalence of peripheral arterial disease (PAD) and ass...
Background: Peripheral artery disease is a type of cardiovascular disease which belongs to vascular ...
To know the epidemiology (prevalence, incidence, progression and morbidity and mortality associated)...
Objectives: To determine the prevalence of and the risk factors for Peripheral arterial disease (PAD...
AbstractObjectivesThe association of peripheral arterial occlusive disease (PAD) association with ma...
Abstract Background: To investigate the presence of peripheral artery disease (PAD) via the ankle br...
To compare the prevalence of lower extremity peripheral artery disease (PAD) and to assess whether a...
Objective To determine cardiovascular comorbidities and use of cardiovascular disease preventive dru...
Asintomático; Factores de riesgo cardiovascular; PrevalenciaAsimptomàtic; Factors de risc cardiovasc...
BACKGROUND: The primary aim of the present study was to determine the cumulative effect of a set of ...
AbstractObjectivesTo determine the prevalence of ankle-brachial index (ABI)<0.9 and symptomatic peri...
Background: the early diagnosis of atherosclerotic disease is essential for developing preventive st...
_Background:_ Cardiovascular diseases (CVD) are the most important cause of mortality in Latin Ameri...
Abstract Background The early diagnosis of atherosclerotic disease is essential for developing preve...
textabstractBackground: Cardiovascular diseases (CVD) are the most important cause of mortality in L...
Objective: To determine the age-standardised prevalence of peripheral arterial disease (PAD) and ass...
Background: Peripheral artery disease is a type of cardiovascular disease which belongs to vascular ...
To know the epidemiology (prevalence, incidence, progression and morbidity and mortality associated)...
Objectives: To determine the prevalence of and the risk factors for Peripheral arterial disease (PAD...
AbstractObjectivesThe association of peripheral arterial occlusive disease (PAD) association with ma...
Abstract Background: To investigate the presence of peripheral artery disease (PAD) via the ankle br...
To compare the prevalence of lower extremity peripheral artery disease (PAD) and to assess whether a...
Objective To determine cardiovascular comorbidities and use of cardiovascular disease preventive dru...